Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening

被引:12
|
作者
Prefumo, F [1 ]
Thilaganathan, B [1 ]
机构
[1] St George Hosp, Sch Med, Fetal Med Unit, Dept Obstet & Gynaecol, London SW17 ORE, England
关键词
Down syndrome; prenatal screening; nuchal translucency; first trimester; validation;
D O I
10.1002/pd.432
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The agreement between predicted risks of Down syndrome and observed prevalence was investigated in a population of 11847 singleton pregnancies screened by first trimester nuchal translucency at a single institution. Twenty-seven cases of Down syndrome were observed; 20 were detected prenatally by nuchal translucency and maternal age screening, three by other means and four postnatally. The screened women were grouped according to their predicted risk of having an affected pregnancy, and this was compared with the observed prevalence. A significant correlation between predicted and observed prevalences was noted, thus demonstrating that risk estimates for Down syndrome based on first trimester nuchal translucency screening are accurate. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:917 / 918
页数:2
相关论文
共 50 条
  • [41] Patient access to nuchal translucency ultrasound for first trimester prenatal screening
    Matteson, Jamie
    Goldman, Sara
    Flessel, Monica
    Currier, Robert
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (01) : S360 - S360
  • [42] Nuchal translucency measurements for first-trimester screening: The 'Price' of inaccuracy
    Evans, Mark I.
    Van Decruyes, Hilde
    Nicolaides, Kypros H.
    FETAL DIAGNOSIS AND THERAPY, 2007, 22 (06) : 401 - 404
  • [43] Nuchal translucency, first trimester screening for chromosomal anomalies: the total picture
    Bilardo, CM
    Pajkrt, E
    Muller, M
    2ND INTERNATIONAL CONGRESS ON NEW TECHNOLOGIES IN REPRODUCTIVE MEDICINE, NEONATOLOGY AND GYNECOLOGY, 1999, : 69 - 72
  • [44] First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency
    Orlandi, F
    Damiani, G
    Hallahan, TW
    Krantz, DA
    Macri, JN
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1997, 10 (06) : 381 - 386
  • [45] Screening for fetal chromosomal abnormalities with nuchal translucency measurement in the first trimester
    Has, R
    Kalelioglu, I
    Ermis, H
    Ibrahimoglu, L
    Yuksel, A
    Yildirim, A
    Basaran, S
    FETAL DIAGNOSIS AND THERAPY, 2006, 21 (04) : 355 - 359
  • [46] First trimester screening for structural fetal abnormalities: Nuchal translucency sonography
    Devine, PC
    Malone, FD
    SEMINARS IN PERINATOLOGY, 1999, 23 (05) : 382 - 392
  • [47] Quality assessment in prospective nuchal translucency screening for Down syndrome
    Wojdemann, KR
    Christiansen, M
    Sundberg, K
    Larsen, SO
    Shalmi, A
    Tabor, A
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (06) : 641 - 644
  • [48] Distribution of nuchal translucency in antenatal screening for Down's syndrome
    Bestwick, J. P.
    Huttly, W. J.
    Wald, N. J.
    JOURNAL OF MEDICAL SCREENING, 2010, 17 (01) : 8 - 12
  • [49] Congenital nephrotic syndrome presenting with increased nuchal translucency in the first trimester
    Souka, AP
    Skentou, H
    Geerts, L
    Bower, S
    Nicolaides, KH
    PRENATAL DIAGNOSIS, 2002, 22 (02) : 93 - 95
  • [50] Intracranial translucency assessment at first trimester nuchal translucency ultrasound
    Lane, Annah
    Lee, Ling
    Traves, Donna
    Lee, Andreas
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2017, 61 (02) : 185 - 189